Goldman Sachs analysts, led by David Kostin, warned that the S&P 500 rally may face further headwinds following a recent 5% ...

We recently published a list of 11 AI News and Ratings You Probably Missed. In this article, we are going to take a look at ...

Sunrun (NASDAQ:RUN – Free Report) had its price target reduced by The Goldman Sachs Group from $17.00 to $15.00 in a research note issued to investors on Monday,Benzinga reports. The Goldman Sachs ...

With a market cap of $194.2 billion, The Goldman Sachs Group, Inc. (GS) is a leading global financial institution providing ...

Shares of Redfin Co. (NASDAQ:RDFN – Get Free Report) have been given a consensus rating of “Hold” by the ten ratings firms ...

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) shares reached a new 52-week low on Monday after The Goldman Sachs Group lowered their price target on the stock from $29.00 to $15.00. The ...

The Goldman Sachs Group lowered shares of SK Telecom (NYSE:SKM – Free Report) from a buy rating to a neutral rating in a report released on Monday morning, Marketbeat.com reports. Other research ...

Italy's unemployment rate fell slightly to 6.3% in January from an upwardly revised 6.4% the month before, national ...

The Indian rupee closed slightly higher on Tuesday tracking a rise in Asian peers, while dollar demand from importers and ...

Redfin (NASDAQ:RDFN – Free Report) had its price target reduced by JPMorgan Chase & Co. from $8.00 to $7.00 in a research report sent to investors on Monday,Benzinga reports. They currently have a ...

South Africa's economy returned to modest growth in the fourth quarter of last year after a small contraction in the previous ...

Iovance Biotherapeutics (NASDAQ:IOVA – Free Report) had its price objective trimmed by Truist Financial from $25.00 to $15.00 in a research note issued to investors on Monday morning,Benzinga reports.